Melanoma Insights for Professionals
By Melanoma Institute Australia
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Melanoma Institute Australia
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 12
Reviews: 0
Episodes: 38
Description
Melanoma Insights for Professionals brings you conversations with leading multidisciplinary experts who break down the latest research and best practice into what it actually means in the clinic.
Developed by Melanoma Institute Australia, this podcast helps healthcare professionals stay ahead of developments in melanoma and complex skin cancer—while uncovering the thinking behind expert clinical decision-making.
| Episode | Date |
|---|---|
|
From collaboration to innovation: How multidisciplinary teams and clinical trials are transforming melanoma care
|
Jul 17, 2026 |
|
Redefining Immunotherapy (Ep. 5): Hype vs Reality: The Future of Immunotherapy
|
Jun 07, 2026 |
|
Redefining Immunotherapy (Ep. 4): Melanoma Treatment Strategy: Expert Perspectives
|
May 31, 2026 |
|
[Trailer] Redefining Immunotherapy (Ep. 4): Melanoma Treatment Strategy
|
May 28, 2026 |
|
Redefining Immunotherapy (Ep. 3): Immunotherapy Toxicity: Prevention, Early Recognition and Management to Optimise Outcome
|
May 24, 2026 |
|
Redefining Immunotherapy (Ep. 2): Predict, Treat, Monitor: The Quest for Smarter Immunotherapy Decisions
|
May 17, 2026 |
|
Redefining Immunotherapy (Ep. 1): Beyond the Tumour: Rethinking Cancer in the Immunotherapy Era
|
May 11, 2026 |
|
After the diagnosis: Getting follow-up care right in melanoma
|
Dec 02, 2025 |
|
Overdiagnosis or early detection? The controversy of melanoma in situ
|
Oct 21, 2025 |
|
Utilising melanoma risk prediction tools for newly diagnosed patients
|
Aug 15, 2025 |
|
Sentinel node biopsy in melanoma: Still recommended in 2025?
|
Jun 20, 2025 |
|
Integrating AI in melanoma care
|
May 14, 2025 |
|
The future of melanoma detection and management: Perspectives from world-leading clinicians
|
Nov 05, 2024 |
|
Unveiling melanoma research: Shaping the future with innovative research infrastructure
|
Sep 02, 2024 |
|
Transforming cancer care: Neoadjuvant therapy and trials in melanoma care
|
Jun 03, 2024 |
|
Current and emerging biomarkers for melanoma care
|
May 21, 2024 |
|
Spotlight on mucosal melanoma: Head and neck
|
Apr 02, 2024 |
|
Dealing with diagnostic uncertainty and borderline pathology
|
Nov 29, 2023 |
|
Melanoma: When do I scan?
|
Sep 27, 2023 |
|
When to recommend a sentinel node biopsy in melanoma
|
Jul 07, 2023 |
|
Neoadjuvant immunotherapy: Revolutionising melanoma treatment
|
Mar 13, 2023 |
|
Unravelling lentigo maligna
|
Feb 06, 2023 |
|
Diagnosis and management of uveal melanoma
|
Nov 16, 2022 |
|
Getting the pathology right: Melanoma in General Practice
|
Aug 31, 2022 |
|
Critical questions for a melanoma pathologist
|
Jun 27, 2022 |
|
Toxicity management in melanoma
|
May 17, 2022 |
|
The evolving paradigm shift in melanoma
|
Feb 10, 2022 |
|
Multidisciplinary management of in-transit melanoma
|
Oct 27, 2021 |
|
Multidisciplinary management of primary melanoma
|
Jun 29, 2021 |
|
Multidisciplinary management of Merkel cell carcinoma
|
Apr 28, 2021 |
|
Multidisciplinary management of SCC and BCC
|
Mar 30, 2021 |
|
The complexities of adjuvant therapy in melanoma
|
Feb 10, 2021 |
|
Emerging therapies in advanced melanoma in 2020
|
Jun 29, 2020 |
|
Melanoma in children and adolescents
|
Mar 15, 2020 |
|
When should I refer to a melanoma clinic?
|
Dec 10, 2019 |
|
What GPs need to know about melanoma patients on systemic therapies
|
Oct 02, 2019 |
|
Food, Mood and Move in Melanoma
|
May 27, 2019 |
|
Management of Brain Metastases in Melanoma
|
Mar 22, 2019 |